[Adenosine triphosphate for supraventricular tachycardia in newborns and suckling infants]

Dtsch Med Wochenschr. 1994 Oct 7;119(40):1351-6. doi: 10.1055/s-2008-1058845.
[Article in German]

Abstract

A previously healthy and normally developing 12-day-old female suddenly became restless and developed cold sweats, tachypnoea and tachycardia (300 beats/min). Neither electrocardiogram nor echocardiogram showed evidence of any cardiac defect. Carotid sinus massage and other vagus-stimulating manoeuvres, undertaken because paroxysmal supraventricular tachycardia (PSVT) was suspected, were unsuccessful. Before rapid digitalization, adenosine triphosphate was administered (0.1 mg/kg intravenously). Sinus rhythm was restored within about 60 s. Despite further treatment with digoxin and verapamil (4 mg/kg.d), further episodes of PSVT occurred, each again responding to ATP (0.1 to 0.3 mg/kg). There were no side effects. After 24-hour Holter ECG monitoring had revealed Wolff-Parkinson-White syndrome as cause of the PSVT, propafenone was administered (15 mg/kg daily) and has prevented further recurrence of the tachycardia.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adenosine Triphosphate / therapeutic use*
  • Digoxin / therapeutic use
  • Drug Therapy, Combination
  • Echocardiography
  • Electrocardiography
  • Electrocardiography, Ambulatory
  • Female
  • Humans
  • Infant, Newborn
  • Propafenone / therapeutic use
  • Tachycardia, Supraventricular / drug therapy*
  • Tachycardia, Supraventricular / etiology
  • Verapamil / therapeutic use
  • Wolff-Parkinson-White Syndrome / complications*
  • Wolff-Parkinson-White Syndrome / diagnosis
  • Wolff-Parkinson-White Syndrome / drug therapy

Substances

  • Propafenone
  • Digoxin
  • Adenosine Triphosphate
  • Verapamil